eXIthera

0 followers

‌

eXIthera is the leader in Factor XIa inhibition, the ideal target for anticoagulation, preventing thrombosis without an increased risk of bleeding.

Industries

Headquarters

Employees

Links

Org chart

Neil J. Hayward

CEO, President, & Co-Founder

Neil J. Hayward

Collapse

Michael Kurz

VP, Translational Medicine & Medical Affairs

Paula M. Bokesch

Head, Clinical Development

Bert L. Chenard

Head, Chemistry

Priya Jambhekar

Head, Regulatory Affairs

Andy Hu

Head, Corporate & Business Development

William Koster

Director (Chairman)

Teams

Advisory and Director Team

12 members

Leadership Team

2 members

Similar companies

AbbVie

152 followers

Incyte

14 followers

Novavax

7 followers

Recursion Pharmaceuticals

6 followers

Amgen

181 followers

PTC Therapeutics

8 followers

Amneal Pharmaceuticals

5 followers

Bristol-Myers Squibb

165 followers

Thermo Fisher Scientific

143 followers

Genentech

144 followers

Gilead Sciences

121 followers

Discover companies